Bavarian Nordic originally developed the vaccine in collaboration with the US Government as a smallpox vaccine suitable for a broad population, including people with weakened immune systems who cannot receive traditional replicating smallpox vaccines.
The announcement comes two years after the companies began their collaboration, although neither has explained the delay in publicly disclosing the agreement.
Both type 1 and type 2 diabetes can cause CKD, although type 2 diabetes accounts for a larger proportion of cases because it is more common.
The expanded network will strengthen Lonza’s capacity across bioconjugates, high-potency compounds, viral vectors and lipid-based delivery technologies.
The oral drug was being evaluated in adults with MSA, a rare and progressive neurodegenerative disorder that affects movement, coordination and balance.
The collaboration will initially focus on biosimilar versions of Roche’s cancer treatment Polivy and Amgen’s thyroid eye disease therapy Tepezza.
Barbados joins a group of 26 countries and territories worldwide recognized by WHO for eliminating mother-to-child transmission of HIV, syphilis or hepatitis B, or for being on track to achieve elimination.
Long-acting injectables (LAIs) could offer an alternative by reducing the frequency of doses and the need for repeated medication administration.
The Medicines and Healthcare products Regulatory Agency (MHRA) approved the expanded indication, lowering the minimum eligible age from 12 to five years for both conditions.
Lonza also plans to introduce 500-litre single-use manufacturing capacity across its existing mid-scale bioconjugation facilities from 2027.